SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Maes M, Bosmans E, Suy E, DeJonckheere C, Raus J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1β and soluble interleukin-2 receptor production. Acta Psychiatr. Scand. 1991; 84: 379386.
  • 2
    Maes M, Wauters A, Neels H et al. Total serum protein and serum protein fractions in depression: Relationships to depressive symptoms and glucocorticoid activity. J. Affect. Disord. 1995; 34: 6169.
  • 3
    Maes M, Delange J, Ranjan R et al. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs. Psychiatry Res. 1997; 66: 111.
  • 4
    Maes M, De Vos N, Demedts P, Annick W, Neels H. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J. Affect. Disord. 1999; 56: 189194.
  • 5
    Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J. Affect. Disord. 1994; 30: 283288.
  • 6
    Sluzewska A, Rybakowski J, Bosmans E et al. Indicators of immune activation in major depression. Psychiatry Res. 1996; 64: 161167.
  • 7
    Huang TL. Lower serum albumin levels in patients with mood disorders. Chang Gung Med. J. 2002; 25: 509513.
  • 8
    Huang TL, Lin FC. High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar I disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007; 31: 370372.
  • 9
    Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukine-6. Immunol. Today 1990; 170: 443449.
  • 10
    Seidel A, Arolt V, Hunstriger M, Rink L, Behnisch A, Kirchner H. Cytokine production and serum proteins in depression. Scand. J. Immunol. 1995; 41: 534538.
  • 11
    Huang TL, Chen JF. Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis and inflammation/immunity. Adv. Clin. Chem. 2005; 39: 81105.
  • 12
    Smith RS. The macrophage theory of depression. Med. Hypotheses 1991; 35: 298306 (Erratum in Med. Hypotheses 1991; 36: 178).
  • 13
    Kronfol Z, Remick DG. Cytokines and the brain: Implications for clinical psychiatry. Am. J. Psychiatry 2000; 157: 683694.
  • 14
    Leonard B. Stress, depression and the activation of the immune system. World J. Biol. Psychiatry 2000; 1: 1725.
  • 15
    Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29: 201217.
  • 16
    Myint AM, Leonard BE, Steinbusch HWM, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J. Affect. Disord. 2005; 88: 167173.
  • 17
    Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. N.Y. Acad. Sci. 2006; 1069: 6276.
  • 18
    Pavon L, Sandoval-Lopez G, Eugenia Hernandez M et al. Th2 cytokine response in major depressive disorder patients before treatment. J. Neuroimmunol. 2006; 172: 156165.
  • 19
    Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145173.
  • 20
    O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8: 275283.
  • 21
    Liew FY. TH1 and TH2 cells: A historical perspective. Nat. Rev. Immunol. 2001; 2: 5560.
  • 22
    Maes M, Smith RS. Fatty acids, cytokines and major depression. Biol. Psychiatry 1998; 43: 313314.
  • 23
    Kubera M, Lin AH, Kenis G, Bosmans E, Van Bockstaele D, Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J. Clin. Psychopharmacol. 2001; 21: 199206.
  • 24
    Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J. Affect. Disord. 2001; 63: 171178.
  • 25
    Nakano Y, Nakamura S, Hirata M et al. Immune function and lifestyle of taxi drivers in Japan. Ind. Health 1998; 36: 3239.
  • 26
    Marshall GD, Agarwal SK, Lloyd C, Cohen L, Henninger EM, Morris GJ. Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav. Immun. 1998; 12: 297307.
  • 27
    Corcos M, Guilbaud O, Paterniti S et al. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: Preliminary findings. Psychoneuroendocrinology 2004; 29: 686691.
  • 28
    Swain SL, Huston G, Tonkonogy S, Weinberg AD. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 1991; 147: 29913000.
  • 29
    Schmitt E, Hoehn P, Heuls C et al. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interteukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 1994; 24: 793798.
  • 30
    Rothermundt M, Arolt V, Peters M et al. Inflammatory markers in major depression and melancholia. J. Affect. Disord. 2001; 63: 93102.
  • 31
    Rothermundt M, Arolt V, Fenker J et al. Different immune patterns in melancholic and non-melancholic major depression. Eur. Arch. Psychiatry Clin. Neurosci. 2001; 251: 9097.
  • 32
    Kaestner F, Hettich M, Peters M et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J. Affect. Disord. 2005; 87: 305311.
  • 33
    Fisrt MB, Spitzer RL, Gibbon M, Williams JBW. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders–Clinician Version (SCID-CV). American Psychiatric Press, Washington, DC, 1997.
  • 34
    Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 5662.
  • 35
    Nishizawa Y, Shoji T, Ishimura E. Body composition and cardiovascular risk in hemodialysis patients. J. Ren. Nutr. 2006; 16: 241244.
  • 36
    Erten Y, Tulmac M, Derici U et al. An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients. Ren. Fail. 2005; 27: 581589.
  • 37
    Berry MA, Hargadon B, Shelley M et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N. Engl. J. Med. 2006; 354: 697708.
  • 38
    Yang CM, Hsieh HL, Lee CW. Intracellular signaling mechanism underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung Med. J. 2005; 28: 813823.
  • 39
    Tracey KJ, Cerami A. Tumor necrosis factor: A pleiotropic cytokine and the therapeutic target. Annu. Rev. Med. 1994; 45: 491503.
  • 40
    Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA. Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 1990; 40: 17351739.
  • 41
    Sheng JG, Boop FA, Mrak RE, Griffin WS. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: Association with interleukin-1 alpha immunoreactivity. J. Neurochem. 1994; 63: 18721879.
  • 42
    Simen BB, Duman CH, Simen AA, Duman RS. TNFα signaling in depression and anxiety: Behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006; 59: 775785.
  • 43
    Leonard BE. The HPA and immune axes in stress: The involvement of the serotonergic system. Eur. Psychiatry 2005; 3: S302S306.
  • 44
    Weiner HL. Oral tolerance: Immune mechanisms and the generation of Th-3 type TGF-beta-secreting regulatory cells. Microbes Infect. 2001; 3: 947954.
  • 45
    Marques-Deak AH, Neto FL, Dominguez WV et al. Cytokine profiles in women with different subtypes of major depressive disorder. J. Psychiatr. Res. 2007; 41: 152159.